QuantRx Biomedical Corporation
QTXB · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $449 | $495 | $464 | $787 |
| - Cash | $4 | $2 | $6 | $6 |
| + Debt | $2,829 | $2,683 | $2,691 | $2,637 |
| Enterprise Value | $3,274 | $3,176 | $3,149 | $3,418 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$61 | -$81 | -$57 | -$61 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | 20% | -42.9% | 12.5% | – |
| Operating Cash Flow | -$4 | -$29 | -$0 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$29 | -$0 | -$15 |